Literature DB >> 21734121

Antimalarial drug sensitivity profile of western Kenya Plasmodium falciparum field isolates determined by a SYBR Green I in vitro assay and molecular analysis.

Hoseah M Akala1, Fredrick L Eyase, Agnes C Cheruiyot, Angela A Omondi, Bernhards R Ogutu, Norman C Waters, Jacob D Johnson, Mark E Polhemus, David C Schnabel, Douglas S Walsh.   

Abstract

In vitro drug sensitivity and molecular analyses of Plasmodium falciparum track drug resistance. DNA-binding fluorescent dyes like SYBR Green I may allow field laboratories, proximal to P. falciparum collection sites, to conduct drug assays. In 2007-2008, we assayed 121 P. falciparum field isolates from western Kenya for 50% inhibitory concentrations (IC(50)) against 6 antimalarial drugs using a SYBR Green I in vitro assay: 91 immediate ex vivo (IEV) and 30 culture-adapted, along with P. falciparum reference clones D6 (chloroquine [CQ] sensitive) and W2 (CQ resistant). We also assessed P. falciparum mdr1 (Pfmdr1) copy number and single nucleotide polymorphisms (SNPs) at four codons. The IC(50)s for IEV and culture-adapted P. falciparum isolates were similar, and approximated historical IC(50)s. For Pfmdr1, mean copy number was 1, with SNPs common at codons 86 and 184. The SYBR Green I assay adapted well to our field-based laboratory, for both IEV and culture-adapted P. falciparum, warranting continued use.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21734121      PMCID: PMC3122340          DOI: 10.4269/ajtmh.2011.10-0674

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  40 in total

1.  Over-the-counter sale of antimalaria drugs stalls Kenyan disease strategy.

Authors:  S Siringi
Journal:  Lancet       Date:  2001-06-09       Impact factor: 79.321

2.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

Review 3.  Drug resistant malaria on the Thai-Myanmar and Thai-Cambodian borders.

Authors:  C Wongsrichanalai; J Sirichaisinthop; J J Karwacki; K Congpuong; R S Miller; L Pang; K Thimasarn
Journal:  Southeast Asian J Trop Med Public Health       Date:  2001-03       Impact factor: 0.267

4.  Drug susceptibility and genetic evaluation of Plasmodium falciparum isolates obtained in four distinct geographical regions of Kenya.

Authors:  Abigael Mbaisi; Pamela Liyala; Fredrick Eyase; Rachel Achilla; Hosea Akala; Julia Wangui; Josphat Mwangi; Finnley Osuna; Uzma Alam; Bonnie L Smoak; Jon M Davis; Dennis E Kyle; Rodney L Coldren; Carl Mason; Norman C Waters
Journal:  Antimicrob Agents Chemother       Date:  2004-09       Impact factor: 5.191

5.  Assessment of malaria in vitro drug combination screening and mixed-strain infections using the malaria Sybr green I-based fluorescence assay.

Authors:  Edgie-Mark A Co; Richard A Dennull; Drew D Reinbold; Norman C Waters; Jacob D Johnson
Journal:  Antimicrob Agents Chemother       Date:  2009-04-06       Impact factor: 5.191

6.  Antifolate drug resistance and point mutations in Plasmodium falciparum in Kenya.

Authors:  B Khan; S Omar; J N Kanyara; M Warren-Perry; J Nyalwidhe; D S Peterson; T Wellems; S Kaniaru; J Gitonga; F J Mulaa; D K Koech
Journal:  Trans R Soc Trop Med Hyg       Date:  1997 Jul-Aug       Impact factor: 2.184

7.  The SYBR Green I malaria drug sensitivity assay: performance in low parasitemia samples.

Authors:  Matthias G Vossen; Sandra Pferschy; Peter Chiba; Harald Noedl
Journal:  Am J Trop Med Hyg       Date:  2010-03       Impact factor: 2.345

8.  Simple and inexpensive fluorescence-based technique for high-throughput antimalarial drug screening.

Authors:  Martin Smilkstein; Nongluk Sriwilaijaroen; Jane Xu Kelly; Prapon Wilairat; Michael Riscoe
Journal:  Antimicrob Agents Chemother       Date:  2004-05       Impact factor: 5.191

9.  Characteristics of Plasmodium falciparum dhfr haplotypes that confer pyrimethamine resistance, Kilifi, Kenya, 1987--2006.

Authors:  Laura K Certain; Marnie Briceño; Steven M Kiara; Alexis M Nzila; William M Watkins; Carol Hopkins Sibley
Journal:  J Infect Dis       Date:  2008-06-15       Impact factor: 5.226

10.  Molecular epidemiology of drug-resistant malaria in western Kenya highlands.

Authors:  Daibin Zhong; Yaw Afrane; Andrew Githeko; Liwang Cui; David M Menge; Guiyun Yan
Journal:  BMC Infect Dis       Date:  2008-07-31       Impact factor: 3.090

View more
  19 in total

1.  Inhibitory activity of ferroquine, versus chloroquine, against western Kenya Plasmodium falciparum field isolates determined by a SYBR Green I in vitro assay.

Authors:  Fredrick L Eyase; Hoseah M Akala; Jacob D Johnson; Douglas S Walsh
Journal:  Am J Trop Med Hyg       Date:  2011-12       Impact factor: 2.345

2.  Adaptation and optimization of a fluorescence-based assay for in vivo antimalarial drug screening.

Authors:  Maria H Arias; Eric Deharo; Alexis Valentin; Giovanny Garavito
Journal:  Parasitol Res       Date:  2017-05-16       Impact factor: 2.289

3.  Assessment of the Worldwide Antimalarial Resistance Network Standardized Procedure for In Vitro Malaria Drug Sensitivity Testing Using SYBR Green Assay for Field Samples with Various Initial Parasitemia Levels.

Authors:  Agnes C Cheruiyot; Jennifer M Auschwitz; Patricia J Lee; Redemptah A Yeda; Charles O Okello; Susan E Leed; Mayank Talwar; Tushar Murthy; Heather W Gaona; Mark R Hickman; Hoseah M Akala; Edwin Kamau; Jacob D Johnson
Journal:  Antimicrob Agents Chemother       Date:  2016-03-25       Impact factor: 5.191

4.  Impact of Short-Term Storage on Ex Vivo Antimalarial Susceptibilities of Fresh Ugandan Plasmodium falciparum Isolates.

Authors:  Martin Okitwi; Stephen Orena; Katairo Thomas; Patrick K Tumwebaze; Oswald Byaruhanga; Samuel L Nsobya; Melissa D Conrad; Brett R Bayles; Philip J Rosenthal; Roland A Cooper
Journal:  Antimicrob Agents Chemother       Date:  2022-03-10       Impact factor: 5.938

5.  Reduced in vitro doxycycline susceptibility in plasmodium falciparum field isolates from Kenya is associated with PfTetQ KYNNNN sequence polymorphism.

Authors:  Angela O Achieng; Luiser A Ingasia; Dennis W Juma; Agnes C Cheruiyot; Charles A Okudo; Redemptah A Yeda; Jelagat Cheruiyot; Hoseah M Akala; Jacob Johnson; Ben Andangalu; Fredrick Eyase; Walter G Z O Jura; Edwin Kamau
Journal:  Antimicrob Agents Chemother       Date:  2014-07-28       Impact factor: 5.191

6.  Ex vivo drug sensitivity profiles of Plasmodium falciparum field isolates from Cambodia and Thailand, 2005 to 2010, determined by a histidine-rich protein-2 assay.

Authors:  Stuart D Tyner; Chanthap Lon; Youry Se; Delia Bethell; Doung Socheat; Harald Noedl; Darapiseth Sea; Wichai Satimai; Kurt Schaecher; Wiriya Rutvisuttinunt; Mark M Fukuda; Suwanna Chaorattanakawee; Kritsanai Yingyuen; Siratchana Sundrakes; Panjaporn Chaichana; Piyaporn Saingam; Nillawan Buathong; Sabaithip Sriwichai; Soklyda Chann; Ans Timmermans; David L Saunders; Douglas S Walsh
Journal:  Malar J       Date:  2012-06-13       Impact factor: 2.979

7.  Optimizing the HRP-2 in vitro malaria drug susceptibility assay using a reference clone to improve comparisons of Plasmodium falciparum field isolates.

Authors:  Wiriya Rutvisuttinunt; Suwanna Chaorattanakawee; Stuart D Tyner; Paktiya Teja-Isavadharm; Youry Se; Kritsanai Yingyuen; Panjaporn Chaichana; Delia Bethell; Douglas S Walsh; Chanthap Lon; Mark Fukuda; Duong Socheat; Harald Noedl; Kurt Schaecher; David L Saunders
Journal:  Malar J       Date:  2012-09-13       Impact factor: 2.979

8.  The role of Pfmdr1 and Pfcrt in changing chloroquine, amodiaquine, mefloquine and lumefantrine susceptibility in western-Kenya P. falciparum samples during 2008-2011.

Authors:  Fredrick L Eyase; Hoseah M Akala; Luiser Ingasia; Agnes Cheruiyot; Angela Omondi; Charles Okudo; Dennis Juma; Redemptah Yeda; Ben Andagalu; Elizabeth Wanja; Edwin Kamau; David Schnabel; Wallace Bulimo; Norman C Waters; Douglas S Walsh; Jacob D Johnson
Journal:  PLoS One       Date:  2013-05-13       Impact factor: 3.240

9.  Plasmodium falciparum with multidrug resistance 1 gene duplications, Senegal.

Authors:  Aurélie Pascual; Bécaye Fall; Nathalie Wurtz; Mansour Fall; Cheikhou Camara; Aminata Nakoulima; Eric Baret; Bakary Diatta; Boubacar Wade; Sébastien Briolant; Bruno Pradines
Journal:  Emerg Infect Dis       Date:  2013-05       Impact factor: 6.883

10.  Direct comparison of the histidine-rich protein-2 enzyme-linked immunosorbent assay (HRP-2 ELISA) and malaria SYBR green I fluorescence (MSF) drug sensitivity tests in Plasmodium falciparum reference clones and fresh ex vivo field isolates from Cambodia.

Authors:  Suwanna Chaorattanakawee; Stuart D Tyner; Chanthap Lon; Kritsanai Yingyuen; Wiriya Ruttvisutinunt; Siratchana Sundrakes; Piyaporn Sai-gnam; Jacob D Johnson; Douglas S Walsh; David L Saunders; Charlotte A Lanteri
Journal:  Malar J       Date:  2013-07-12       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.